Lijuan Fu

Lijuan Fu is an accomplished scientist with extensive experience in drug metabolism and pharmacokinetics (DMPK). Currently serving as Principal Scientist at BridgeBio since November 2021, Lijuan Fu specializes in nonclinical development, leading DMPK efforts, collaborating with chemistry and pharmacology teams, and managing CROs for ADME/PK studies. Previously at Arcus Biosciences, Lijuan Fu held roles as Principal Investigator and Senior Scientist/Bioanalytical Lead, overseeing bioanalytical teams for pharmacokinetic and toxicokinetic studies. With earlier positions at SCIEX, Covance, and as a postdoctoral fellow at the University of California, Riverside, Lijuan Fu has developed advanced LC-MS methods for quantifying small molecules in biological matrices. Lijuan Fu holds a PhD in Environmental Toxicology from the University of California, Riverside, as well as master's and bachelor's degrees in Analytical Chemistry and Chemistry from China Agricultural University.